Main advantage of Russian vaccine against COVID-19 is named

Chief Researcher at the Chumakov Institute, Academician of the Russian Academy of Sciences, Professor Alexei Egorov spoke about the main difference between the coronavirus vaccine, which is being developed at the Institute, from its analogues.

“The main difference of this vaccine is that it is not made from individual coronavirus antigens, but from a whole inactivated virus. Therefore, it provides a complete set of all antigens of this virus, and this gives a complete set of all antibodies”, – Egorov explained.

According to the scientist, this vaccine will give the body the most extensive protection against coronavirus. The drug will be roughly ready in February next year.